Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana 70112, USA.
J Hypertens. 2010 Apr;28(4):756-63. doi: 10.1097/HJH.0b013e3283370d32.
We examined the association between genetic variants in the apelin system and blood pressure (BP) responses to low-sodium and high-sodium interventions in the GenSalt Study.
A 7-day low-sodium intervention (51.3 mmol sodium per day) followed by a 7-day high-sodium intervention (307.8 mmol sodium per day) was conducted among 1906 participants from 637 Han Chinese families. BP measurements were obtained at baseline and following each intervention using a random-zero sphygmomanometer. Twenty-three single nucleotide polymorphisms (SNPs), including both tag and functional SNPs, were selected from three candidate genes (APLN, APLNR, and ACE2). Single marker and haplotype analyses were conducted using the Family Based Association Test program. The false discovery rate method was used to correct for multiple testing.
SNPs rs2282623 and rs746886 of the APLNR gene were significantly associated with DBP (both P = 0.002) and mean arterial pressure (MAP) (P = 0.001 and 0.005, respectively) responses to low-sodium intervention. Six SNPs of the ACE2 gene were significantly associated with SBP, DBP, or MAP responses to low-sodium intervention. Three of them, rs1514283, rs1514282, and rs4646176, were also significantly associated with MAP response to high-sodium intervention (all P <or= 0.006). Haplotype analysis indicated the A-T-T haplotype of APLNR SNPs rs721608-rs2282623-rs746886 was associated with decreased DBP and MAP responses to low-sodium intervention (P = 0.001 and 0.003, respectively), whereas G-C-C was associated with increased SBP and MAP responses to high-sodium intervention (P = 0.004 and 0.01, respectively).
This large family-based study indicates that genetic variants in the APLNR and ACE2 genes are significantly associated with BP responses to dietary sodium intervention.
我们研究了 apelin 系统的基因变异与 GenSalt 研究中低钠和高钠干预对血压(BP)反应之间的关联。
在 637 个汉族家庭的 1906 名参与者中进行了为期 7 天的低钠干预(每天 51.3mmol 钠),随后进行了为期 7 天的高钠干预(每天 307.8mmol 钠)。使用随机零式血压计在基线和每次干预后测量 BP。从三个候选基因(APLN、APLNR 和 ACE2)中选择了 23 个单核苷酸多态性(SNP),包括标记和功能 SNP。使用 Family Based Association Test 程序进行单标记和单倍型分析。使用错误发现率方法对多重检验进行校正。
APLNR 基因的 rs2282623 和 rs746886 与 DBP(均 P=0.002)和平均动脉压(MAP)(分别为 P=0.001 和 0.005)对低钠干预的反应显著相关。ACE2 基因的 6 个 SNP 与 SBP、DBP 或 MAP 对低钠干预的反应显著相关。其中 3 个 SNP(rs1514283、rs1514282 和 rs4646176)与 MAP 对高钠干预的反应也显著相关(均 P≤0.006)。单倍型分析表明,APLNR SNP rs721608-rs2282623-rs746886 的 A-T-T 单倍型与 DBP 和 MAP 对低钠干预的反应降低相关(分别为 P=0.001 和 0.003),而 G-C-C 与 SBP 和 MAP 对高钠干预的反应增加相关(分别为 P=0.004 和 0.01)。
这项大型基于家庭的研究表明,APLNR 和 ACE2 基因的遗传变异与饮食钠干预对 BP 的反应显著相关。